Availability of energetic substrates and exercise performance in heart failure with or without diabetes

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Heart Failure

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurjhf/hfs080PMID 22696515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls.

  2011cited by this paper
• Body mass indices and outcome in patients with chronic heart failure

  2011cited by this paper
• Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features

  2011cited by this paper
• Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure

  2011cited by this paper
• Metabolic characterization of volume overload heart failure due to aorto-caval fistula in rats

  2011cited by this paper
• Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Cardiac output does not limit submaximal exercise capacity in patients with chronic heart failure

  2010cited by this paper
• Neurohormonal profile of patients with heart failure and diabetes

  2010cited by this paper
• Plasma Copeptin and the Risk of Diabetes Mellitus

  2010cited by this paper
• Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function.

  2010cited by this paper
• The Randle cycle revisited: a new head for an old hat.

  2009cited by this paper
• Substrate Utilization by the Failing Human Heart by Direct Quantification Using Arterio-Venous Blood Sampling

  2009cited by this paper
• Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.

  2007influential reference
• Metabolic mechanisms in heart failure.

  2007influential reference
• Free Fatty Acid Depletion Acutely Decreases Cardiac Work and Efficiency in Cardiomyopathic Heart Failure

  2006cited by this paper
• Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure

  2006cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005influential reference
• Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.

  2005cited by this paper
• Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium.

  2005cited by this paper
• Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure

  2003cited by this paper
• A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure.

  2002cited by this paper
• Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

  2000cited by this paper
• Effect of altering substrate availability on metabolism and performance during intense exercise.

  2000cited by this paper
• Myocardial substrate metabolism influences left ventricular energetics in vivo.

  2000cited by this paper
• Hormones and hemodynamics in heart failure.

  1999cited by this paper
• Free fatty acid kinetics and oxidation in congestive heart failure.

  1998cited by this paper
• Blood ketone bodies in congestive heart failure.

  1996cited by this paper
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.

  1996cited by this paper
• Total-body and myocardial substrate oxidation in congestive heart failure.

  1994cited by this paper
• Metabolic responses to graded exercise in chronic heart failure.

  1993cited by this paper
• Metabolic and cardiovascular benefits deriving from beta-adrenergic blockade in chronic congestive heart failure.

  1992influential reference
• Metabolic and cardiovascular benefits deriving from β-adrenergic blockade in chronic congestive heart failure

  1992cited by this paper
• Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

  1991cited by this paper
• Substrate utilization during exercise in chronic cardiac failure.

  1990cited by this paper
• Lactate, pyruvate, and lactate-to-pyruvate ratio during exercise and recovery.

  1985cited by this paper
• Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

  1984cited by this paper
• Regional blood flow during acute heart failure in dogs. Role of adipose tissue perfusion in regulating plasma-free fatty acids.

  1983cited by this paper
• Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS).

  1979cited by this paper
• Exercise stress testing.

  1977cited by this paper
• Total body fat, calculated from body density, and its relationship to skinfold thickness in 571 people aged 12-72 years.

  1973cited by this paper

• Circulating beta‐hydroxybutyrate levels in advanced heart failure with reduced ejection fraction: Determinants and prognostic impact

  2024cites this paper
• Exercising heart failure patients: cardiac protection through preservation of mitochondrial function and substrate utilization?

  2023cites this paper
• Pyruvate Levels in Sweat as A Surrogate Biomarkerfor Intracellular Mitochondrial Metabolite Flux andSupplement Intervention

  2020cites this paper
• Ketone body metabolism in failing heart.

  2020cites this paper
• Novel Concepts in Cardiac Energy Metabolism: From Biology to Disease

  2019cites this paper
• Loss of Metabolic Flexibility in the Failing Heart

  2018cites this paper
• Predictive value of plasma copeptin level for the risk and mortality of heart failure: a meta‐analysis

  2017cites this paper
• Glucose Homeostasis, Pancreatic Endocrine Function, and Outcomes in Advanced Heart Failure

  2017cites this paper
• Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies.

  2016cites this paper
• Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction

  2015cites this paper
• Heart failure highlights in 2012–2013

  2014cites this paper
• Relationships between right ventricular function, body composition, and prognosis in advanced heart failure.

  2013cites this paper
• Imaging the cardiac diet

  2013cites this paper
• Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failure.

  2013cites this paper